An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-FU (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

Nom du journal : Breast Cancer Res Treat

Année : 2001

Volume : 70

Page de départ : 55

Page de fin : 63

Auteurs: Bonnefoi H, Biganzoli L, Cufer T, Mauriac L, Hamilton A, Schaefer P, Piccart M, Hasford J,